<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02812797</url>
  </required_header>
  <id_info>
    <org_study_id>2016-38-2</org_study_id>
    <nct_id>NCT02812797</nct_id>
  </id_info>
  <brief_title>Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure</brief_title>
  <official_title>Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chongqing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether expressions of adipokines can provide
      prognostic information concerning patients with chronic heart failure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>Change from Baseline at 3, 6 and 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA) Classification</measure>
    <time_frame>Week:4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>re-hospitalization</measure>
    <time_frame>Change from Baseline at 3, 6 and 12 months</time_frame>
    <description>Heart failure with re-hospitalization is documented by at least one of the following: worse exercise tolerance and respiratory distress with NYHA class III or IV symptoms, presence of pulmonary rales, or chest radiography showing pulmonary congestion, which needs an augmented decongestive regimen with oral or intravenous medications during an in-hospital stay.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma brain natriuretic peptide (BNP) concentration</measure>
    <time_frame>Week:4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>Change from Baseline at 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac transplantation</measure>
    <time_frame>Change from Baseline at 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Chronic Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients With Chronic Heart Failure
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are giving open chest surgical treatment with a history of chronic heart
             failure (NYHA II ~ IV) more than 6 months.

          -  Patients from whom informed consent has been properly obtained in writing prior to
             start of the trial.

        Exclusion Criteria:

          -  Patients with concurrent infection or any documented inflammatory illness, such as
             arthritis or connective tissue diseases,or any other malignancy.

          -  Patients with a history of cardiomyopathy.

          -  Patients with Chronic arrhythmia.

          -  Pregnant women

          -  Severe hepatic dysfunction or End-stage renal failure.

          -  Uncontrolled hypertension.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dongying Zhang, doctor</last_name>
    <role>Study Director</role>
    <affiliation>Chongqing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dongying Zhang, doctor</last_name>
    <phone>+8613608398395</phone>
    <email>zdy.chris@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongying Zhang, Doctor</last_name>
      <phone>+8613608398395</phone>
      <email>zdy.chris@qq.com</email>
    </contact>
    <investigator>
      <last_name>Lei Gao, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2016</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Gao Lei</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Adipokines</keyword>
  <keyword>Chronic Heart Failure</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

